Cargando…
Personalised neoantigen‐based therapy in colorectal cancer
Colorectal cancer (CRC) has become one of the most common tumours with high morbidity, mortality and distinctive evolution mechanism. The neoantigens arising from the somatic mutations have become considerable treatment targets in the management of CRC. As cancer‐specific aberrant peptides, neoantig...
Autores principales: | Zhu, Ya‐Juan, Li, Xiong, Chen, Ting‐Ting, Wang, Jia‐Xiang, Zhou, Yi‐Xin, Mu, Xiao‐Li, Du, Yang, Wang, Jia‐Ling, Tang, Jie, Liu, Ji‐Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623652/ https://www.ncbi.nlm.nih.gov/pubmed/37921274 http://dx.doi.org/10.1002/ctm2.1461 |
Ejemplares similares
-
Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
por: Yu, Yao-Jun, et al.
Publicado: (2023) -
Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021) -
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020) -
GNIFdb: a neoantigen intrinsic feature database for glioma
por: Li, Wendong, et al.
Publicado: (2022) -
Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)